Background Atogepant is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist that is being investigated for the preventive treatment of migraine.Methods In a phase 3, double-blind trial, we randomly assigned adults with 4 to 14 migraine days per month in a 1:1:1:1 ratio to re...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!